Skip to main content

Table 1 Epidemiological, clinical and laboratory characteristics of patients with cirrhosis

From: Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study

 

Patients

All n = 244

Compensated n = 101

Decompensated n = 143

Age#

56 (49–65)

54 (49–64)

57 (51–65)

Sex (m/f)

124/120

47/54

77/66

Alcoholic etiology*

137 (56.1%)

36 (35.6%)

101 (70.6%)

Child-

A

153 (62.7%)

97 (96.0%)

56 (39.2%)

Pugh

B

80 (32.8%)

4 (4.0%)

76 (53.1%)

Stage*

C

11 (4.5%)

0 (0.0%)

11 (7.7%)

MELD score#

11 (8–14)

9 (7–12)

12 (9–14)

Bilirubin (μmol/L)#

26 (15–42)

18 (13–30)

30 (19–51)

Albumin (g/L)#

38 (33–42)

42 (37–45)

36 (31–40)

Creatinine (μmol/L)#

67 (54–83.5)

62 (52–76)

70 (55–88)

INR#

1.17 (1.09–1.31)

1.11 (1.05–1.21)

1.22 (1.12–1.36)

WBC (103/ml)

5.26 (4.19–7.14)

5.55 (4.25–7.85)

5.24 (4.05–6.89)

CRP (mg/L)#

3.84 (1.19–7.94)

1.41 (0.50–3.95)

5.67 (2.58–9.87)

Anemia*o

98 (40.2%)

23 (22.8%)

75 (52.4%)

Previous VB*

59 (24.2%)

0 (0.0%)

59 (41.3%)

Ascites*

88 (36.1%)

0 (0.0%)

88 (61.5%)

Comorbidity*

127 (52%)

47 (46.5%)

80 (55.9%)

HCC*

26 (10.7%)

12 (11.9%)

14 (9.8%)

Ferritin (μg/L)#

121.2 (39.7–310.8)

133.7 (49.2–370.1)

103.4 (35.8–271.9)

Ferritin (L/M/H)

61/122/61

22/48/31

39/74/30

  1. m/f male/female, MELD model for end stage liver disease, INR international normalized ratio, WBC white blood cells, CRP C-reactive protein, VB variceal bleeding, HCC hepatocellular carcinoma, L/M/H low/medium/high
  2. #Median (interquartile range); *n (%); odetermined by low hemoglobin and/or hematocrit levels